Eli Lilly and Company is announcing a massive new set of investments in U.S. manufacturing. The company plans to more than double its investments since 2020, bringing the total to more than $50 billion. "To deliver on our big bets on next-generation modalities like small molecules, biologics and nucleic acid therapies, Lilly is investing in the state-of-the-art manufacturing infrastructure needed to deliver tomorrow's safe and reliable medicines," Edgardo Hernandez, executive vice president and president of Lilly Manufacturing Operations, said in a statement. "We are not just building facilities. We are creating a future where American innovation leads the world in pharmaceutical manufacturing, requiring a highly skilled workforce prepared to shape the future of health care. This is a significant step for our company, our communities and the patients we serve." MORE: https://www.wthr.com/article/money/business/eli-lilly-us-united-states-american-domestic-manufacturing-drug-company-wegovy-zepbound-and-company-lebanon-indianapolis-leap-district/531-a5608200-bab1-46a9-a023-1ba8e2db5fd0